Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07542496
What this trial is testing

Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease

Who this might be right for
Breast CancerHer 2 Positive Breast Cancer
Société Algérienne de Formation et Recherche en Oncologie 1,000
Large-scale testing (Phase 3)Study completedNCT05073315
What this trial is testing

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 425
Not applicableLooking for participantsNCT06271018
What this trial is testing

TocILizumab in aorTitis in GCA (TILT)

Who this might be right for
AortitisGiant Cell Arteritis (GCA)
Groupe français d'étude des Maladies Inflammatoires de loeil 80
Not applicableUnknownNCT05530785
What this trial is testing

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Yongchang Zhang 35
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Not applicableUnknownNCT05424393
What this trial is testing

Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients

Who this might be right for
Rheumatoid Arthritis
The First Affiliated Hospital of Xiamen University 500
Not applicableStudy completedNCT03452501
What this trial is testing

Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseFistulizing Crohn's Disease+1 more
Hikma Pharmaceuticals LLC 157
Testing effectiveness (Phase 2)UnknownNCT04215159
What this trial is testing

Trastuzumab Biosimilar (Samfenet®) Plus Treatment of Physician's Choice (TPC) in Patients With HER2-positive Solid Tumor

Who this might be right for
HER-2 Protein OverexpressionHER-2 Gene Amplification
Jin-Hee Ahn 42
Large-scale testing (Phase 3)Study completedNCT04607980
What this trial is testing

Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 563
Not applicableStudy completedNCT04808739
What this trial is testing

Adalimumab Biosimilar in Clinical Practice

Who this might be right for
Psoriasis
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 604
Large-scale testing (Phase 3)UnknownNCT03404752
What this trial is testing

Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.

Who this might be right for
Breast Cancer
Gema Biotech S.A. 120
Not applicableUnknownNCT05190484
What this trial is testing

BIosimilar of aDalimumab, an European evAluation

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis+2 more
Fresenius Kabi 1,050
Large-scale testing (Phase 3)UnknownNCT05853354
What this trial is testing

Comparative Efficacy, Safety, PK, and Immunogenicity Study

Who this might be right for
Osteoporosis, Postmenopausal
Luye Pharma Group Ltd. 392
Large-scale testing (Phase 3)Study completedNCT03079063
What this trial is testing

Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency

Who this might be right for
Factor VII Deficiency
AryoGen Pharmed Co. 24
Post-approval studies (Phase 4)Study completedNCT06624943
What this trial is testing

Introducing Biosimilar Insulin Glargine to the Treatment Regimen of Children and Youth with Type 1 Diabetes in Mali

Who this might be right for
Type 1 Diabetes (T1D)
Life for a Child Program, Diabetes Australia 260
Not applicableStudy completedNCT02191150
What this trial is testing

Study of Haemodialysis Patients Switching From Aranesp to Biosimilar

Who this might be right for
Anaemia
Amgen 272
Large-scale testing (Phase 3)Not Yet RecruitingNCT05850546
What this trial is testing

Rituximab in the First Episode of Paediatric Nephrotic Syndrome

Who this might be right for
Steroid-Sensitive Nephrotic Syndrome
Children's Hospital of Fudan University 138
Not applicableStudy completedNCT03348046
What this trial is testing

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan

Who this might be right for
Rheumatoid Arthritis
Hikma Pharmaceuticals LLC 22
Early research (Phase 1)Not Yet RecruitingNCT07829588
What this trial is testing

Pharmacokinetic (PK) Study of QL1203 and Vectibix® for the Treatment of RAS Wild-type Metastatic Colorectal Cancer

Who this might be right for
RAS Wild-type Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 136
Early research (Phase 1)UnknownNCT03757936
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination With Avastin Biosimilar (HLX04) in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Shanghai Henlius Biotech 30
Next Page